BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38430735)

  • 1. Derivation of an induced pluripotent stem cell line (FDCHi014-A) from PBMCs of a seven-year-old patient with a truncating NOVA2 variant (c.625del).
    Yin T; Qian Y; Zhang X; Liao Y; Wu B; Wang S; Wang H
    Stem Cell Res; 2024 Apr; 76():103369. PubMed ID: 38430735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and characterization of a human iPSC line SANi005-A containing the gray platelet associated heterozygous mutation p.Q287* in GFI1B.
    Hansen M; Varga E; Wüst T; Mellink C; van der Kevie-Kersemaekers AM; Marneth AE; von Lindern M; van der Reijden B; van den Akker E
    Stem Cell Res; 2017 Dec; 25():34-37. PubMed ID: 29055225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of an induced pluripotent stem cell line (SDQLCHi044-A) from a patient with autosomal dominant mental retardation type 5 harboring heterozygous mutation in SYNGAP1 gene.
    Wang Y; Lv Y; Yang X; Li Y; Li Z; Gao Z; Gai Z; Liu Y
    Stem Cell Res; 2022 Oct; 64():102922. PubMed ID: 36183676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of an induced pluripotent stem cell lines HMSCASTi002-A from peripheral blood mononuclear cells of a 38-year-old healthy female individual.
    Xian X; Liu J; Zhang J; Hao P; Zhai Y; Cheng J; Yue F; Ma M; Zhang Z; Luan F; Ren Q
    Stem Cell Res; 2022 Oct; 64():102907. PubMed ID: 36099765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Derivation of human induced pluripotent stem cell (iPSC) line from a 79year old sporadic male Parkinson's disease patient.
    Zhang S; Liu L; Hu Y; Lv Z; Li Q; Gong W; Sha H; Wu H
    Stem Cell Res; 2017 Mar; 19():43-45. PubMed ID: 28413004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of induced pluripotent stem cell line, NIMHi009-A, from PBMCs of an adult healthy male.
    Arunachal G; Milind Nimonkar M; Raghavendra K; Chetan GK; Mehta B; Markandeya YS
    Stem Cell Res; 2024 Apr; 76():103349. PubMed ID: 38368738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of an induced pluripotent stem cell line (KNIHi001-A) by reprogramming peripheral blood mononuclear cells isolated from a patient with Parkinson's disease.
    Baek D; Lee KG; Sohn HY; Park JH; Lee HK; Bayarsaikhan G; Yoo SW; Lee B; Kim JS; Koh YH; Kwon M
    Stem Cell Res; 2024 Apr; 76():103358. PubMed ID: 38447455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of NOVA2 gene variant in a child with Neurodevelopmental disorder with or without autistic features and/or structural brain abnormalities].
    Zhang G; Li S; Yang L; Wang M; Chen G; Zhu D
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Feb; 40(2):213-216. PubMed ID: 36709943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a human induced pluripotent stem cell (iPSC) line from a 64year old male patient with multiple schwannoma.
    Zhang S; Lv Z; Hu Y; Liu L; Gong W; Li Q; Wu H
    Stem Cell Res; 2017 Mar; 19():49-51. PubMed ID: 28413006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of an induced pluripotent stem cell line (SDASi001-A) from a Schimke immune-osseous dysplasia patient with SMARCAL1 mutations.
    Wang X; Zhang H; Wang X; Zhou W; Dong L; Li N; He Q
    Stem Cell Res; 2023 Oct; 72():103217. PubMed ID: 37788557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced human pluripotent stem cells (HEBHMUi013-A) derived from a patient of sporadic Alzheimer's disease.
    Cao S; Guo R; Fu Z; Liu Y; Wu T; Zhou Z; Zhang J; Liu X; Song Y; Ma J
    Stem Cell Res; 2023 Apr; 68():103052. PubMed ID: 36870256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of human induced pluripotent stem cell (iPSC) line from a 60year old female patient with multiple schwannoma.
    Zhang S; Lv Z; Liu Y; Li Q; Gong W; Liu L; Wu H
    Stem Cell Res; 2017 Mar; 19():31-33. PubMed ID: 28413001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a human iPSC line (SUTCMi001-A) derived from a healthy donor.
    Min L; Yin Y; Zhao Q; Wang S
    Stem Cell Res; 2022 Aug; 63():102849. PubMed ID: 35843020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of an induced pluripotent stem cell line BIOi002-A from a patient with autosomal dominant optic atrophy.
    Zhang XH; Xie Y; Xu K; Li Y
    Stem Cell Res; 2021 May; 53():102278. PubMed ID: 33752025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and characterisation of a human induced pluripotent stem cell line, NIMHi007-A, from peripheral blood mononuclear cells derived from an adult healthy female.
    Nimonkar MM; Arunachal G; Dash SS; Kandy SK; Raghavendra K; Chetan GK; Mehta B; Markandeya YS
    Stem Cell Res; 2023 Aug; 70():103130. PubMed ID: 37269666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of pluripotent stem cell line induced by PATL2 heterozygous mutation in patients with oocyte maturation defect-4.
    Xue N; Wang Y; Xu X; Jiang X; Li C; Wang J; Zhou P; Cao Y; Wei Z
    Stem Cell Res; 2022 May; 61():102776. PubMed ID: 35397397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a novel human induced pluripotent stem cell line (SIPDi001-A) with compound heterozygous mutations in the UBR7 gene from a Li-Campeau syndrome patient.
    Li B; Zhou Y; Che F; Zhou R; Mo L; Zhang L; Wang G; Yang Y
    Stem Cell Res; 2023 Sep; 71():103165. PubMed ID: 37478672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of PLAFMCi004-A induced pluripotent stem cells derived from PBMCs from a healthy individual.
    Shang S; Chen K; Cai G; Bai X; Chen X; Li Q
    Stem Cell Res; 2021 May; 53():102316. PubMed ID: 33878710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of an induced pluripotent stem cell line (SDCHi001-A) from a healthy Chinese child donor.
    Wang L; Zeng Q; Wang S; Wu D; Wang J; Zhang H; Lv X
    Stem Cell Res; 2024 Feb; 74():103278. PubMed ID: 38118205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of an induced pluripotent stem cell line (GWCMCi005-A) from a patient with Lennox-Gastaut syndrome carrying TANC2 Gln1441Ter mutation.
    Tian Y; Shi Z; Liao Y; Cai J; Li W; Li X; Chen WX
    Stem Cell Res; 2022 Apr; 60():102667. PubMed ID: 35066241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.